Cargando…
Efficacy and Safety of Direct-Acting Oral Anticoagulants (DOACs) in the Overweight and Obese
Obesity plays an essential role in the safety of pharmacologic drugs. There is paucity of data for direct oral anticoagulants (DOACs) in the obese, despite these agents becoming more widely used. The primary and secondary objectives of this study were to assess the safety and efficacy of DOACs in th...
Autores principales: | Doucette, Kimberley, Latif, Hira, Vakiti, Anusha, Tefera, Eshetu, Patel, Bhavisha, Fitzpatrick, Kelly |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262658/ https://www.ncbi.nlm.nih.gov/pubmed/32528538 http://dx.doi.org/10.1155/2020/3890706 |
Ejemplares similares
-
Laboratory Monitoring of Direct Oral Anticoagulants (DOACs)
por: Dunois, Claire
Publicado: (2021) -
Novel reversal agents and laboratory evaluation for direct-acting oral anticoagulants (DOAC): An update
por: Shah, Shagun B, et al.
Publicado: (2019) -
Direct-acting oral anticoagulants (DOACs) in pregnancy: new insight from VigiBase(®)
por: Sessa, Maurizio, et al.
Publicado: (2019) -
New Direct Oral Anticoagulants (DOAC) and Their Use Today
por: Schwarb, Heike, et al.
Publicado: (2016) -
Can We Improve on the Rapid Assessment of Clinically Relevant Levels of
Direct Acting Oral Anticoagulants (DOAC)?
por: Walenga, Jeanine M.
Publicado: (2022)